<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2016-07-11 17:00:21Medical research Pharmacology Health Food and Drug Administration Pharmaceutical industry Clinical research Drug discovery PEGylation Pharmacokinetics Savient pharmaceuticals Pegloticase FDA Special Protocol Assessment |
Add to Reading List |
Microsoft Word - Savient press release Puricase SPAdoc![SL-35: Oncology Phenotypic Screening. Macrocycles. Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For exa](https://www.pdfsearch.io/img/4b02d42f9851bfe75651c493e50c552b.jpg "SL-35: Oncology Phenotypic Screening. Macrocycles. Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For exa")
